141 related articles for article (PubMed ID: 26118352)
1. Patients perception of self-administrated medication in the treatment of hereditary angioedema.
Wang A; Fouche A; Craig TJ
Ann Allergy Asthma Immunol; 2015 Aug; 115(2):120-5. PubMed ID: 26118352
[TBL] [Abstract][Full Text] [Related]
2. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.
Bygum A; Andersen KE; Mikkelsen CS
Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579
[TBL] [Abstract][Full Text] [Related]
3. Challenges of C1-inhibitor concentrate self-administration.
Boysen HB; Bouillet L; Aygören-Pürsün E
Int Arch Allergy Immunol; 2013; 161 Suppl 1():21-5. PubMed ID: 23689241
[TBL] [Abstract][Full Text] [Related]
4. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hereditary angioedema due to C1 inhibitor deficiency in Argentina.
Malbrán E; Menéndez A; Malbrán A
Medicina (B Aires); 2017; 77(4):279-282. PubMed ID: 28825570
[TBL] [Abstract][Full Text] [Related]
6. Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema.
Petraroli A; Squeglia V; Di Paola N; Barbarino A; Bova M; Spanò R; Marone G; Triggiani M
Int Arch Allergy Immunol; 2015; 166(4):259-66. PubMed ID: 25924832
[TBL] [Abstract][Full Text] [Related]
7. Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema.
Caballero T; Sala-Cunill A; Cancian M; Craig TJ; Neri S; Keith PK; Boccon-Gibod I; Bethune C; Bork K
Int Arch Allergy Immunol; 2013; 161 Suppl 1():10-6. PubMed ID: 23689239
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous self-injections of C1 inhibitor: an effective and safe treatment in a patient with hereditary angio-oedema.
Weller K; Krüger R; Maurer M; Magerl M
Clin Exp Dermatol; 2016 Jan; 41(1):91-3. PubMed ID: 26011518
[TBL] [Abstract][Full Text] [Related]
10. Current medical management of hereditary angioedema: follow-up survey of US physicians.
Riedl MA; Banerji A; Gower R
J Allergy Clin Immunol Pract; 2015; 3(2):220-7. PubMed ID: 25609328
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of home infusion and self-administration of nanofiltered C1 esterase inhibitor for routine prophylaxis in patients with hereditary angioedema and characterization of a training and support program.
Gregory C; Landmesser LM; Corrigan L; Mariano D
J Infus Nurs; 2014; 37(1):29-34. PubMed ID: 24384882
[TBL] [Abstract][Full Text] [Related]
13. Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.
Shapiro RS; Zacek L
J Infus Nurs; 2014; 37(4):284-90. PubMed ID: 24983261
[TBL] [Abstract][Full Text] [Related]
14. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic agents for hereditary angioedema.
Wuillemin WA
N Engl J Med; 2011 Jan; 364(1):84-5; author reply 85-6. PubMed ID: 21208117
[No Abstract] [Full Text] [Related]
16. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
[TBL] [Abstract][Full Text] [Related]
17. Swedish children with hereditary angioedema report good overall health and quality of life despite symptoms.
Nygren A; Nordenfelt P; Lindfors A; Mallbris L; Björkander J; Wahlgren CF
Acta Paediatr; 2016 May; 105(5):529-34. PubMed ID: 26821285
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary angioedema. Treatment of acute attacks in Argentina].
Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy.
Tourangeau LM; Castaldo AJ; Davis DK; Koziol J; Christiansen SC; Zuraw BL
Int Arch Allergy Immunol; 2012; 157(4):417-24. PubMed ID: 22123229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
